BOSTON, Oct. 1, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and personalized…
Released in time for World Mental Health Day, "Transformed by His Promises" equips readers with clinically informed strategies and structured…
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Today, a coalition of leaders from academia, healthcare, technology, and employee benefits announced the…
BARCELONA, Spain and SALT LAKE CITY and AUSTIN, Texas, Sept. 30, 2025 /PRNewswire/ -- DataJoint, a leading computational database and…
The gold-standard dataset will power a new generation of AI tools to forecast Alzheimer's risk, track progression, and guide interventions…
- Clinical study conducted at the Dementia Research Centre, Nanyang Technological University, Singapore, involving Southeast Asian participants - Expert level accuracy,…
Publication title: “Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of…
-- AjD Represents an Area of Significant Unmet Need; No U.S. Food and Drug Administration (FDA)-Approved Therapies Available -- --…
VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:…
LOUISVILLE, Ky., Sept. 24, 2025 /PRNewswire/ -- Cognision, a leader in high-performance neurophysiological biomarker solutions and services, has announced a…